2025-11-25
10 分钟Good morning from the Financial Times.
Today is Tuesday, November 25th, and this is your FT News briefing.
Traders are gearing up for tomorrow's autumn budget,
and we'll give you an update on Europe's pharmaceutical sector.
Plus, European countries are grumpy with Ireland over its weak defenses.
We'll see if that can change.
I'm Mark Filipino, and here's the news you need to start your day.
A bunch of investors are betting that the UK budget will send the pound lower against the dollar.
Chancellor Rachel Reeves is unveiling her budget tomorrow.
Traders are worried that she'll raise taxes and that would hurt an already struggling economy.
Now an increase in taxes has long been expected.
The pound is sliding on this and it's close to its weakest level against the dollar since April.
Good news for Bayer and bad news for Novo Nordisk in the pharmaceutical sector this week.
Bayer shares rose on reports of a successful trial for its stroke prevention medicine.
Novo shares slid on news that one of its diabetes drugs had failed to slow the progression of Alzheimer's.
Here to explain is the FT's Anu Etioye, who covers the sector.
Thanks for joining us Anu.
Thanks for having me.
All right, let's deal with the good news first.
Tell us about Bayer's new anti-stroke medicine.